Moreover, LINC00665 is important for NSCLC to develop drug resistance, and in cells with acquired gefitinib resistance, downregulation of the LINC00665 gene reverses gefitinib sensitivity in vitro and in vivo53. This evidence concerns the gene LINC00665 and non-small cell lung carcinoma.